Mechanistically, KLF5 exerts these functions as a novel pro-angiogenic factor in bladder cancer by directly regulating the transcription of VEGFA, which is the most prominent factor among the angiogenic cytokines [14–16]. The gene discussed is KLF5; the disease is urinary bladder carcinoma.